Cargando…
Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
Emerging evidence has demonstrated that radiotherapy (RT) can not only cause direct damage to cancer cells but also lead to immunogenic cell death (ICD), which involves the activation of host antitumor immune response in tumor immune microenvironment (TIME). RT-induced ICD comprises the release of d...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284706/ https://www.ncbi.nlm.nih.gov/pubmed/35836249 http://dx.doi.org/10.1186/s13046-022-02430-1 |